Apollomics, Inc. (APLM)
NASDAQ: APLM · IEX Real-Time Price · USD
0.198
-0.011 (-5.23%)
Jul 22, 2024, 9:58 AM EDT - Market open
Apollomics Employees
Apollomics had 45 employees as of December 31, 2023. The number of employees increased by 2 or 4.65% compared to the previous year.
Employees
45
Change (1Y)
2
Growth (1Y)
4.65%
Revenue / Employee
n/a
Profits / Employee
-$3,835,578
Market Cap
22.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 45 | 2 | 4.65% |
| Dec 31, 2022 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ekso Bionics Holdings | 72 |
| Biora Therapeutics | 58 |
| HCW Biologics | 45 |
| Inspira Technologies Oxy B.H.N. | 42 |
| Sol-Gel Technologies | 36 |
| Nephros | 31 |
| BioVie | 18 |
| NeuroOne Medical Technologies | 16 |
APLM News
- 5 days ago - Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 19 days ago - Apollomics Announces Updated Strategic Focus and Leadership Team Changes - GlobeNewsWire
- 3 months ago - Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene - GlobeNewsWire
- 3 months ago - Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 4 months ago - Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer - GlobeNewsWire
- 5 months ago - Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 months ago - Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire